Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BMS-770767
Cat. No.:
OB0425LY-018
Appearance:
Solid
Purity:
99.9%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
BMS-770767 is an 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor that is primarily used to target specific tyrosine kinases.
Synonyms:
1875067-34-7; 4-(8-(2-Chlorophenoxy)(1,2,4)triazolo(4,3-a)pyridin-3-yl)bicyclo(2.2.1)heptan-1-ol; 4-(8-(2-Chlorophenoxy)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)bicyclo[2.2.1]heptan-1-ol
CAS No.:
1875067-34-7
Compound CID:
57809036
Formula:
C19H18ClN3O2
Formula Weight:
355.82
Specification
Target:
11β-HSD
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
BMS-770767 plays an important role in metabolic diseases such as diabetes and obesity.
